Free Trial

Astera Labs, Inc. (NASDAQ:ALAB) Receives Consensus Rating of "Moderate Buy" from Brokerages

Astera Labs logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Consensus "Moderate Buy" from 22 analysts (15 buys, 6 holds, 1 sell) with an average 1‑year price target of $199.44.
  • Strong Q4 results: EPS $0.58 vs. $0.51 expected and revenue $270.6M (up 91.8% YoY), with Q1 2026 guidance of $0.530–$0.540 EPS.
  • Notable insider selling: insiders have sold 577,292 shares (~$69.5M) in the last 90 days (including CEO and GC sales), though insiders still own about 12.5% of the company.
  • MarketBeat previews the top five stocks to own by June 1st.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the twenty-two research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $199.4444.

Several analysts have issued reports on the company. Weiss Ratings cut Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Monday, February 23rd. Barclays set a $165.00 price objective on Astera Labs in a report on Thursday, January 15th. Citigroup started coverage on Astera Labs in a report on Thursday, April 2nd. They set a "buy" rating and a $200.00 price objective for the company. Loop Capital started coverage on Astera Labs in a report on Thursday, March 5th. They set a "buy" rating and a $250.00 price objective for the company. Finally, Royal Bank Of Canada started coverage on Astera Labs in a report on Wednesday, January 14th. They set an "outperform" rating and a $225.00 price objective for the company.

Read Our Latest Research Report on ALAB

Astera Labs Trading Up 3.2%

Shares of NASDAQ ALAB opened at $129.46 on Friday. The stock has a market capitalization of $22.17 billion, a PE ratio of 106.11, a price-to-earnings-growth ratio of 2.47 and a beta of 1.78. The stock's fifty day simple moving average is $128.14 and its two-hundred day simple moving average is $156.21. Astera Labs has a 12-month low of $52.56 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analysts' expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business's revenue for the quarter was up 91.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts predict that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insider Activity

In other news, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the sale, the general counsel owned 118,084 shares in the company, valued at approximately $12,725,912.68. This represents a 7.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 157,500 shares of the stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00. Following the sale, the chief executive officer owned 4,531,732 shares of the company's stock, valued at approximately $596,285,296.56. This represents a 3.36% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 577,292 shares of company stock worth $69,495,249. Company insiders own 12.50% of the company's stock.

Institutional Trading of Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Lido Advisors LLC raised its stake in Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company's stock worth $2,046,000 after acquiring an additional 57 shares during the last quarter. Perigon Wealth Management LLC raised its stake in Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company's stock worth $208,000 after acquiring an additional 73 shares during the last quarter. Clearstead Advisors LLC raised its stake in Astera Labs by 13.6% in the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company's stock worth $125,000 after acquiring an additional 76 shares during the last quarter. Sound Income Strategies LLC raised its stake in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company's stock worth $164,000 after acquiring an additional 76 shares during the last quarter. Finally, Venturi Wealth Management LLC raised its stake in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company's stock worth $546,000 after acquiring an additional 84 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Read More

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines